Merck Reaffirms Commitment to Safe, Effective Vaccination for Children
Rahway, N.J., Jan. 8, 2026 — Merck today reaffirms its commitment to protecting the health and safety of children and adolescents by supporting the U.S. Child and Adolescent Immunization Schedule. In partnership with health care providers and families, Merck emphasizes that vaccines play a vital role in preventing disease, reducing hospitalizations, and helping kids grow up healthy and thriving.
Safety, Efficacy, and Transparency
Merck stresses that every vaccine in the U.S. schedule undergoes rigorous evaluation for safety and efficacy before it becomes part of routine care. The company notes that vaccine safety monitoring continues after approval, with ongoing post-market surveillance designed to quickly identify and address any concerns. Public health agencies, clinicians, and researchers work in concert to ensure that the benefits of immunization continue to outweigh any risks.
Why the Schedule Matters
The U.S. immunization schedule is designed to protect children at key ages when vaccines provide the best protection against preventable diseases. By following the schedule, families can help reduce outbreaks, protect vulnerable populations, and minimize missed school days due to illness. Merck highlights that adherence to evidence-based recommendations supports both individual health and community immunity.
Collaboration with Health Care Providers and Parents
Merck acknowledges the essential role of pediatricians, family physicians, nurses, and other health professionals in delivering vaccines and counseling families. The company supports transparent communication about vaccine benefits and potential side effects, helping caregivers make informed decisions in partnership with clinicians. Merck also encourages parents to discuss any questions or concerns with trusted health care providers to ensure vaccines are administered on schedule.
What This Means for Families
For families, the statement reinforces that vaccines are a cornerstone of preventive health care. Following the U.S. schedule helps protect children from diseases that can cause serious illness, long-term health problems, or hospitalization. Merck notes that maintaining timely vaccination supports a child’s ability to attend school and participate in everyday activities with greater confidence in their protection against infectious diseases.
Ongoing Commitment to Public Health
Beyond individual vaccines, Merck remains committed to ongoing research, collaboration with public health authorities, and transparent communication about vaccine safety and effectiveness. The company advocates for science-based decision-making and access to vaccines for all eligible children, with special attention to ensuring that families have reliable information to guide health choices.
About Merck’s Position
Merck’s position aligns with recommendations from the U.S. Centers for Disease Control and Prevention (CDC) and other major health bodies. The company believes that a robust, evidence-driven immunization program is fundamental to a thriving society where children can grow with fewer preventable health risks. The latest statement is intended to reassure families and providers that vaccine safety remains a top priority for Merck as the immunization schedule evolves with new scientific insights.
